在多发性骨髓瘤中揭示因果性免疫细胞基因关联:从系统性审查和门德尔随机化分析的见解
Hui Zhang1,2, Ling Zhang3, Jing-Xuan Lian4
1Department of Traditional Chinese Medicine, Tangdu Hospital, Air Force Medical University (Fourth Military Medical University), Xi'an, China.
Frontiers in medicine
|February 6, 2025
概括
化学抗原受体T细胞 (CAR-T) 治疗显示,多发性骨髓瘤 (MM) 的反应率为82.2%. 门德尔随机分析确定了特定免疫细胞和MM风险之间的因果关系,为疾病病理生理学提供了新的见解.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 对多发性骨髓瘤 (MM) 的化学抗原受体T细胞 (CAR-T) 治疗疗效是可变的,可能是由于对瘤微环境 (TME) 的不完全理解.
- 本研究使用元分析评估CAR-T治疗的疗效和安全性,并通过孟德尔随机化 (MR) 调查免疫细胞和MM之间的因果关系.
研究的目的:
- 评估CAR-T细胞治疗在复发性/耐药性多发性髓瘤 (rrMM) 的疗效和安全性.
- 用MR分析识别因果关系与MM风险相关的免疫细胞类型.
- 确定与MM相关的致病基因,并探索它们的甲基化水平相关性.
主要方法:
- 一项全面的文献审查 (2019年1月至2024年8月) 从2,709篇初始文章中确定了34项相关研究.
- 进行了元分析,以确定CAR-T疗法的整体响应率 (ORR) 和不良事件 (CRS,神经毒性).
- 用GWAS数据的两样MR分析来调查免疫细胞水平和MM风险之间的因果关系,随后进行SMR和同位分析.
主要成果:
- 分析显示,在rrMM中,CAR-T治疗的ORR为82.2%,严重CRS (6.3%) 和神经毒性 (0.9%) 的比例较低.
- 在BCMA,CD38和GPRC5D CAR-T疗法中,反应率更高.
- 核磁共振分析发现了七种与MM风险增加相关的免疫细胞类型,八种与风险降低相关. VDR,VHL,POMC和FANCD2被确定为风险基因,VHL和POMC显示甲基化水平相关性.
结论:
- 对于 rrMM 患者来说,CAR-T 疗法是有效和安全的,具有高ORR和可控毒性.
- BCMA/CD19双特异性CAR-T细胞可能提供更高的ORR,需要进一步的临床验证.
- 这项研究阐明了免疫细胞,特定基因 (如VDR,VHL) 和MM之间的因果关系,从而促进了对其病理生理学的理解.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.6K
相关概念视频
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Autoimmune Disorders
379
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
379
